This inquiry is examining the legal and policy challenges faced in setting up and running the pilot Safer Drugs Consumption Facility (SDCF) which opened in Glasgow in January 2025. This inquiry will examine the case for the facility, as well as its medical effectiveness in reducing drug-related harm in Scotland. The Committee will consider the current legal position of the SDCF, what challenges this presents, and what statutory and policy changes at a UK level might be necessary to enable the facility to operate sustainably beyond its three-year pilot.
This inquiry follows up on relevant aspects of the Scottish Affairs Committee’s previous work on this issue in the 2017-19 Parliament.
Read the terms of reference for more detail about the inquiry.